ABC Transporters and Multidrug Resistance

Ahc?ne Boumendjel is Professor of Medicinal Chemistry at the University of Grenoble School of Pharmacy, France.

Jean Boutonnat is an Assistant Professor and Hospital Practitioner at the Grenoble Medical School and Université Joseph Fourier of Grenoble, France.

Jacques Robert is Professor and Head of the Laboratory of Pharmacology of Anticancer Agents at Institut Bergonié and Université Victor Segalen Bordeaux 2, France.

CONTRIBUTORS.

INTRODUCTION: WHAT IS MULTIDRUG RESISTANCE (Jonathan A. Sheps and Victor Ling).

PART I ABC PROTEINS: AN OVERVIEW AND DESCRIPTION OF THE STRUCTURE, GENOME, NORMAL TISSUE EXPRESSION, PHYSIOLOGICAL ASPECT, AND MECHANISM OF ACTION.

1 The P-glycoprotein 170: Just a multidrug resistance protein or a protean molecule (Fabienne Grandjean-Forestier, Christophe Stenger, Jacques Robert, Mireille Verdier, and Marie-Hélène Ratinaud).

2 Multidrug resistance-associated protein (MRP/ABCC proteins) (Mylène Honorat, Charles Dumontet, and Lea Payen).

3 ABCG2: A new challenge in cancer drug resistance (Orsolya Polgar, Robert W. Robey, Kin Wah To, John Deeken, Patricia A. Fetsch, and Susan E. Bates).

PART II ABC PROTEINS AND ONCOLOGY: EXPRESSION, DETECTION, AND IMPLICATION OF ABC PROTEINS IN HEMATOLOGICAL MALIGNANCIES AND SOLID TUMORS.

4 Expression, detection, and implication of ABC proteins in acute myeloblastic leukemia (Ollivier Legrand, Ruo-Ping Tang, and Jean-Pierre Marie).

5 ABC proteins and oncology: Expression, detection, and implication of ABC proteins in solid tumors (Jean François Bernaudin, Anne Fajac, Jocelyne Fleury-Feith, Khaldoun Kerrou, and Roger Lacave).

PART III ABC PROTEINS AND PATHOGENIC MICROORGANISMS.

6 ABC transporters and resistance to antibiotics (Serge Michalet and Marie-Geneviève Dijoux-Franca).

7 ABC proteins involved in protozoan parasite resistance (Bruno Pradines).

PART IV MULTIDRUG RESISTANCE (MDR) MODULATION THROUGH INHIBITION OF ABC TRANSPORTERS: DESIGN OF INHIBITORS AND MECHANISM OF ACTION.

8 Reversal agents for P-glycoprotein-mediated multidrug resistance (Hamid Morjani and Claudie Madoulet).

9 Reversal agents of multidrug resistance mediated by multidrug resistance-associated proteins (MRPs) (Ahcène Boumendjel, Anne Florin, and Jean Boutonnat).

10 Reversal agents for breast cancer resistance protein (BCRP)-mediated multidrug resistance (Jean Boutonnat, Anne Florin, and Ahcène Boumendjel).

11 Strategies to overcome drug resistance in acute and chronic leukemias (Eric Solary, Vincent Ribrag, and Stéphane de Botton).

12 Multidrug resistance reversal in solid tumors (Tatiana Bogush and Jacques Robert).

PART V BIOLOGICAL AND CLINICAL ASPECTS OF MULTIDRUG RESISTANCE: THE ROLE OF THE TRANSPORTERS AT THE MAIN PROTECTION BARRIERS (ABCB1, ABCC1, ABCC2, ABCG2) ON THE BIOAVAILABILITY OF MANY TYPES OF DRUGS AND MEDICATIONS.

13 ABC superfamily transporters at the human blood–brain barrier (Jean-Michel Scherrmann).

14 The role of ABC transporters at the intestinal barrier (Roos L. Oostendorp, Jos H. Beijnen, and Jan H.M. Schellens).

15 Genetic polymorphisms in ABC transporters (Leslie W. Chinn and Deanna L. Kroetz).

PERSPECTIVES.

INDEX.

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.